Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Zentiva ks specializes in the development, manufacture and marketing of generic pharmaceutical products. It offers generic drugs, over the counter medicines, dietary supplements, cosmetics and pharmaceutical substances. The company's products cover therapy areas of cardiovascular disease, pain, alimentary, genitourinary tract diseases, inflammations and central nervous system diseases including digestive problems. Zentiva was founded in 1989 and is headquartered in Prague, Czech Republic.

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research & development, manufacture, and sale of pharmaceutical products as well as veterinary medicines. Its products include active pharmaceutical ingredients and generic drugs. The company was founded in 1956 and is headquartered in Taizhou, China.

Wuhan Wuyao Technology Co., Ltd., established on 2003-06-10, Business scope includes pharmaceutical,chemical industry,medical instruments,product technology development,technology transfer,Technical Services,technical consulting.

Sinopharm Group Guorui Pharmaceutical Co., Ltd., established on 1998-08-05, The business scope includes freeze-dried powder injection,powder injection(Contains cephalosporins),small volume injection,tablet,hard capsule,API,Sterile API,Psychotropic drugs,inhalant,Healthy food,Daily Chemicals,Production and sales of chemical intermediates,technology transfer,Technical Services,technology development,technical consulting:material transfer:Enterprise Marketing Planning:Business Consulting:market research:Economic Information Consulting:Branding:Acquisition of agricultural and sideline products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Westlake Village, California, the company was founded in February 1991. However, its present form is a result of a 2003 merger of three companies owned by Alfred E. Mann, Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing a allergy vaccine technology. MannKind Corporation was named after its founder, Alfred Mann. One of the former companies, Pharmaceutical Discovery, was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).

Anhui Baker Biopharmaceutical Co., Ltd., established on 2003-12-17, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug import and export;Drug Wholesale;Health food production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Healthy food(prepackaged)Sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Technology Import and Export;Import and export agency(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Jiangsu Tianhe Pharmaceutical Co., Ltd., established on 2007-01-12, The scope of business includes the production of raw materials,API R&D,Sell ​​the company's own products.Self-operated and agent import and export business of various commodities and technologies(Except for goods that are restricted by the state to be operated by enterprises or prohibited from import and export)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Chongqing Shenghuaxi Pharmaceutical Co., Ltd., established on 1999-09-28, The scope of business includes the production of small volume injections,Freeze-dried powder injection,tablet,hard capsule,oral solution,powder injection(Contains cephalosporins),Sterile API,API.(Engage in business according to the approved scope and period of the license)manufacture,Sales of pharmaceutical intermediates;drug research,Development and transfer.(Except for those prohibited by the state,Those that should be approved shall not operate before obtaining the approval)

Nanjing Pinsheng Medical Laboratory Co., Ltd., established on 2018-01-22, Business scope includes licensed projects:Class III medical device business;Production of Class II Medical Devices;medical service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;Health Consulting Services(Does not include medical services);Socioeconomic Advisory Services;Organize cultural and artistic exchange activities;Conference and Exhibition Services;Natural science research and experimental development;Sales of Class I Medical Devices;Sales of Class II Medical Devices;electronics sales;Daily necessities sales;Machinery sales;Manufacturing of computer software, hardware and peripheral equipment;Retailing of computer software, hardware and auxiliary equipment;Information system integration service;Production of Class I Medical Devices;Electrical Equipment Sales;Domestic trade agent;trade broker;marketing planning;sales agent;Machinery and Equipment Leasing;Computer and communication equipment rental;Medical equipment rental;Office equipment rental service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for gastric mucous membrane protection, antihistaminic agents, ischemic improvements, antithrombotic, functional digestion, hyperlipemia cure, growth hormone, anti-peptic ulcer cure, cerebral metabolic, high blood pressure, and others. The company was founded on March 1, 2013 and is headquartered in Seoul, South Korea.

The company is committed to the first imitation and rapid imitation of major and multiple diseases clinically urgent varieties, in cardiovascular, diabetes and other important therapeutic areas to establish a product group, and continue to increase investment to strengthen the accumulation of technology and products; At the same time, the company continues to improve the accumulation of innovation capacity, promote the research and development of innovative drugs, in order to gradually realize the global registered research and development capacity.

Mylan Laboratories Ltd. manufactures and supplies active pharmaceutical ingredients. The firm operates through two segments: Pharmaceuticals and Medical Supplies. It manufactures and supplies generic and branded generic formulations to various markets, including North America, Europe and Asia Pacific. Mylan Laboratories was founded on November 29, 1984 and is headquartered in Hyderabad, India.

National Institute of Pharmaceutical Education & Research (doing business as NIPER) is an Indian company located in Sahibzada Ajit Singh Nagar and ultimately controlled by the Government of India that provides research services in pharmaceutical sciences. It was founded in 1998.

Anhui Biochem Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of antiviral chemical drugs. It offers anti-acquired immunodeficiency syndrome (AIDS) preparations, anti-hepatitis B preparations, chemical intermediates, and active pharmaceutical ingredients. The company was founded by Zhi Bang Wang in March 2003 and is headquartered in Fuyang, China.

Centre for Infectious Disease Research in Zambia (CIDRZ) is an independent, Zambian non-governmental organisation established in 2001. CIDRZ is one of Zambia's largest NGOs supporting health services in all 10 Zambian Provinces. CIDRZ is an active partner of, and aims to be a permanent resource to, the Government of the Republic of Zambia and collaborates with the Ministry of Health, Ministry of Community Development Mother and Child Health, Ministry of Home Affairs Zambian Prisons Service, University of Zambia, and University Teaching Hospital, among others.

Manufactures pharmaceutical products

Lupin Ltd. is an innovation led transnational pharmaceutical company, which engages in the manufacture of pharmaceutical products. It offers branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The firm caters to the cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives, nonsteroidal anti-inflammatory drug therapy, anti-tuberculosis, and cephalosporins industry segments. It operates through the following geographical segments: India, USA, Japan, and Others. The company was founded by Desh Bandhu Gupta in 1968 and is headquartered in Mumbai, India.

Chongqing Huizhi Pharmaceutical Research Institute Co., Ltd., established on 2010-12-28, Business scope includes drugs,Research in Pharmaceutical Technology;Pharmaceutical Chemicals,Intermediate research and technical services;Self-study,Self-owned technological achievements transfer and technical consulting services;Research on Medical Electronic Devices.(law,Prohibited by law,Not allowed to operate;law,regulations,Subject to approval by the State Council,Before approval,Not allowed to operate).